Bulimia Nervosa
📧 Sign up to get email alerts when something new happens for Bulimia Nervosa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Online Cognitive Behavioral Therapy for Bulimia Nervosa [NA]
Clinical trial evaluating online cognitive behavioral therapy for bulimia nervosa has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: A Double Blind Clinical Trial of DCS for Food Anxiety [NA]
A double-blind clinical trial tested D-cycloserine for food anxiety in people with anorexia nervosa and bulimia nervosa; the study is comple…
-
CLINICAL_TRIALS research · 2018-03-21Clinical Trial Update: Dopamine Release to Food Reward in Bulimia Nervosa [NA]
A clinical trial update examining dopamine release in response to food reward in individuals with bulimia nervosa; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Eating Disorders: Online Self-help & Usual Treatment (TAU) vs TAU Only [NA]
A University of Edinburgh trial compared online self-help plus usual treatment to usual treatment alone for eating disorders, and the study …
-
FDA approval · 2017-11-20FDA Approved: FLUOXETINE — Original Application (NIVAGEN PHARMACEUTICALS, INC.)
FDA approved NIVAGEN Pharmaceuticals' original application for fluoxetine hydrochloride, granting marketing approval for a generic version o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-11-16FDA Approved: FLUOXETINE — Original Application (Endo USA, Inc.)
FDA approves Endo USA, Inc.'s original application for a generic fluoxetine product.
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: The Effects of Written Emotional Disclosure on Eating Disorder Pathology in a Clinical Eating Disordered Population
A completed clinical trial examining whether written emotional disclosure reduces eating disorder pathology in individuals with anorexia ner…
-
CLINICAL_TRIALS research · 2017-05-02Clinical Trial Update: Periodontal Impact of Eating Disorders (the PERIOED Study)
This update covers the PERIOED study, which investigates the impact of eating disorders on periodontal health, including anorexia nervosa an…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Effect of a CCK-1R Agonist on Food Intake in Humans [Phase 2]
Phase 2 trial evaluating a CCK-1R agonist for food intake in bulimia; the study was terminated and results were posted in 2017.
-
FDA approval · 2017-04-05FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's original application for fluoxetine hydrochloride (fluoxetine) as a generic drug.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Guided Self-help for Binge Eating [NA]
A completed clinical trial evaluating guided self-help for binge eating and related eating disorders.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder. [NA]
Completed clinical trial comparing treatments for patients with concurrent eating disorders and personality disorders.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Mindfulness Training Effect on Self-monitoring Adherence and Group CBT Outcomes for Binge Eating Disorders [NA]
This clinical trial update examines whether mindfulness training affects self-monitoring adherence and the outcomes of group cognitive-behav…
-
FDA approval · 2017-03-24FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
The FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company. The action updates th…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Virtual Reality Based Cue-exposure Treatment for Bulimia Nervosa [NA]
A study evaluating virtual reality cue-exposure therapy for bulimia nervosa and binge-eating disorder has completed.
-
FDA approval · 2017-01-04FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for PROZAC (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2017-01-04FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for fluoxetine from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2017-01-04FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for a generic fluoxetine hydrochloride product manufactured by Lannett Company, Inc.
-
FDA approval · 2017-01-04FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application from Aurobindo Pharma Limited to market a generic fluoxetine product.
-
FDA approval · 2017-01-04FDA Approved: FLUOXETINE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)
FDA approved a supplemental application for fluoxetine submitted by Saptalis Pharmaceuticals, LLC.
-
FDA approval · 2017-01-04FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for a generic Fluoxetine hydrochloride product from PAI Holdings dba PAI Pharma under ANDA 07601…
-
FDA label_change · 2016-12-28FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for fluoxetine from Dr. Reddy's Laboratories Limited, indicating a labeling-related update to the ge…
-
FDA approval · 2016-12-27FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for fluoxetine hydrochloride from Lannett Company, Inc., resulting in approval of their generic fluo…
-
FDA approval · 2016-12-27FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluoxetine hydrochloride from PAI Holdings, LLC dba PAI Pharma.
-
FDA approval · 2016-12-27FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA granted a supplemental approval for a generic fluoxetine product from Aurobindo Pharma Limited under an ANDA.